IMPROVEMENT OF SCOTOPIC AND MESOPIC NIGHT-SEEING PERFORMANCE OF GLAUCOMA AFFECTED PATIENTS, WITH PROSTAGLANDIN'S AND b-BLOCK- ER TOPICALLY ADMINISTERED THERAPY

We carried out a multicenter blind study on a group of people homogeneous per sex and age (media was 40 years) most of them working as night driver, radar controller, video surveillance. 132 people affected from chronic glaucoma were divided in 4 groups of 33 each. First group was administered timolol, second la-tanoprost, third bimatoprost, fourth travoprost We noticed